Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Paul Awolade

Concepts (100)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Quinolines
2
2021
149
1.500
Why?
Triazoles
3
2021
153
1.410
Why?
Microbial Sensitivity Tests
5
2021
351
0.900
Why?
Antineoplastic Agents
7
2022
2039
0.850
Why?
Structure-Activity Relationship
10
2021
539
0.800
Why?
Isatin
1
2021
1
0.730
Why?
Glucuronidase
1
2019
47
0.670
Why?
DNA Helicases
2
2023
149
0.640
Why?
Molecular Structure
10
2021
469
0.620
Why?
Anti-Bacterial Agents
4
2021
1719
0.590
Why?
Methicillin-Resistant Staphylococcus aureus
1
2021
216
0.580
Why?
Glycoproteins
1
2019
340
0.570
Why?
DNA-Binding Proteins
2
2023
1423
0.530
Why?
Glycoside Hydrolase Inhibitors
1
2021
3
0.420
Why?
Hypoglycemic Agents
3
2021
1206
0.400
Why?
Dose-Response Relationship, Drug
6
2021
1969
0.380
Why?
Thiadiazoles
2
2021
24
0.360
Why?
Cell Survival
2
2021
1083
0.360
Why?
Antitubercular Agents
1
2020
197
0.350
Why?
Aminoquinolines
2
2020
21
0.350
Why?
Molecular Docking Simulation
3
2021
109
0.340
Why?
Breast Neoplasms
1
2021
2112
0.330
Why?
Oxadiazoles
2
2020
35
0.330
Why?
Coumarins
2
2020
21
0.330
Why?
Antifungal Agents
2
2020
132
0.320
Why?
Pyrimidines
1
2020
444
0.310
Why?
Pyrazoles
1
2019
403
0.300
Why?
Anti-Infective Agents
2
2021
249
0.290
Why?
Indoles
2
2020
379
0.280
Why?
Drug Screening Assays, Antitumor
3
2021
195
0.250
Why?
Drug Design
3
2022
157
0.250
Why?
alpha-Glucosidases
1
2021
12
0.250
Why?
Enzyme Inhibitors
2
2019
828
0.240
Why?
DNA Damage
377
NaN
Why?
Drug Synergism
354
NaN
Why?
MCF-7 Cells
2
2021
109
0.220
Why?
Plants, Medicinal
1
2021
22
0.190
Why?
Chalcones
1
2021
9
0.190
Why?
Xenograft Model Antitumor Assays
797
NaN
Why?
Thiazolidines
1
2021
8
0.190
Why?
Triple Negative Breast Neoplasms
185
NaN
Why?
alpha-Amylases
1
2021
16
0.190
Why?
Mycobacterium tuberculosis
1
2020
314
0.180
Why?
HEK293 Cells
2
2020
673
0.180
Why?
Chemistry Techniques, Synthetic
1
2020
13
0.170
Why?
Pyrimidinones
1
2021
102
0.170
Why?
Isoniazid
1
2020
61
0.170
Why?
Isoindoles
1
2019
4
0.170
Why?
Glutamine-Fructose-6-Phosphate Transaminase (Isomerizing)
1
2019
1
0.170
Why?
Antimalarials
1
2019
32
0.170
Why?
Plasmodium falciparum
1
2019
33
0.170
Why?
beta-Lactams
1
2020
30
0.170
Why?
Malaria
1
2019
54
0.160
Why?
Small Molecule Libraries
1
2019
85
0.160
Why?
Cell Proliferation
3
2021
2340
0.160
Why?
Fungi
1
2020
139
0.160
Why?
Cell Line, Tumor
3
2022
3106
0.150
Why?
Anti-Inflammatory Agents
1
2021
471
0.140
Why?
Colorectal Neoplasms
731
NaN
Why?
Pyridines
1
2019
472
0.130
Why?
Humans
15
2023
129706
0.130
Why?
Computer Simulation
1
2020
947
0.130
Why?
Bacteria
1
2020
813
0.110
Why?
Pancreatic Neoplasms
1
2020
881
0.100
Why?
Neoplasms
2
2023
2435
0.100
Why?
Binding Sites
2
2019
1238
0.070
Why?
Fluorouracil
198
NaN
Why?
Diabetes Mellitus, Type 2
1
2018
2424
0.050
Why?
Poly(ADP-ribose) Polymerase Inhibitors
88
NaN
Why?
Drug Repositioning
1
2021
24
0.050
Why?
Oncogenes
1
2022
111
0.050
Why?
Protease Inhibitors
1
2021
104
0.050
Why?
Peptide Hydrolases
1
2021
109
0.050
Why?
Female
1
2021
68562
0.040
Why?
Carcinogenesis
1
2022
200
0.040
Why?
Antioxidants
557
NaN
Why?
Parasitic Sensitivity Tests
1
2019
2
0.040
Why?
Candida albicans
1
2020
53
0.040
Why?
Ciprofloxacin
1
2019
30
0.040
Why?
Microwaves
1
2019
35
0.040
Why?
Drug Resistance, Multiple, Bacterial
1
2019
71
0.040
Why?
Heme
1
2019
77
0.040
Why?
Drug Evaluation, Preclinical
1
2019
173
0.040
Why?
Fructose-Bisphosphatase
1
2018
1
0.040
Why?
Phosphoenolpyruvate Carboxykinase (ATP)
1
2018
15
0.040
Why?
Dipeptidyl Peptidase 4
1
2018
13
0.040
Why?
Sodium-Glucose Transporter 2
1
2018
21
0.040
Why?
Receptors, Glucagon
1
2018
27
0.040
Why?
Protein Tyrosine Phosphatase, Non-Receptor Type 1
1
2018
45
0.040
Why?
Estrogen Receptor alpha
1
2018
132
0.040
Why?
Mice
1
2023
16585
0.030
Why?
Pseudomonas aeruginosa
1
2020
343
0.030
Why?
PPAR gamma
1
2018
182
0.030
Why?
Receptors, G-Protein-Coupled
1
2018
199
0.030
Why?
Antiviral Agents
1
2021
709
0.030
Why?
Antineoplastic Combined Chemotherapy Protocols
1570
NaN
Why?
Apoptosis
2485
NaN
Why?
ErbB Receptors
1
2018
601
0.030
Why?
Disease Models, Animal
4016
NaN
Why?
Animals
1
2023
34733
0.020
Why?
Awolade's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)